Fund Holdings — ARCH Venture Management, LLC

Total Portfolio Value:
$260.56M
Total Bought:
$0
Total Sold:
$9.08M
Net Transaction:
-$9.08M
Notable People:
Robert Taylor Nelsen
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Beam Therapeutics Inc.(BEAM)5,443,0394,834,653-608,386$127.53M$118.45M45.46%-$9.08M
Rapport Therapeutics, Inc.(RAPP)3,728,7383,728,7380$86.73M$76.36M29.31%-$10.37M
Erasca, Inc.(ERAS)11,055,55411,055,5540$26.09M$30.18M11.58%+$4.09M
Q32 Bio Inc.(QTTB)320,482320,4820$5.75M$14.30M5.49%+$8.55M
Verve Therapeutics, Inc.2,008,8092,008,8090$9.80M$9.72M3.73%-$80.4K
Gossamer Bio, Inc.(GOSS)8,055,9168,055,9160$7.26M$7.95M3.05%+$688.8K
Singular Genomics Systems, Inc.126,630126,6300$1.07M$1.98M0.76%+$914.3K
Unity Biotechnology, Inc.1,004,8171,004,8170$1.36M$1.48M0.57%+$120.6K
CERo Therapeutics Holdings, Inc.CL A(CERO)1,444,2961,444,2960$431.8K$134.8K0.05%-$297.1K
Page 1 of 1
ARCH Venture Management, LLC — 13F Holdings — Q3 2024 | TickerTrail